The molecular and gene/miRNA expression profiles of radioiodine resistant papillary thyroid cancer

The molecular and gene/miRNA expression profiles of radioiodine resistant papillary thyroid cancer

Abstract Background Papillary thyroid cancer (PTC) is the most frequent endocrine tumor. Radioiodine (RAI) treatment is highly effective in these tumors, but up to 60% of metastatic cases become RAI-refractory. Scanty data are available on either the molecular pattern of radioiodine refractory papil...

Full description

Bibliographic Details
Main Authors: Carla Colombo, Emanuela Minna, Chiara Gargiuli, Marina Muzza, Matteo Dugo, Loris De Cecco, Gabriele Pogliaghi, Delfina Tosi, Gaetano Bulfamante, Angela Greco, Laura Fugazzola, Maria Grazia Borrello
Format: Article
Language:English
Published: BMC 2020-11-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Thyroid
Oncogenes
Radioiodine refractory
Gene/miRNA profiles
Papillary thyroid cancer
Online Access:http://link.springer.com/article/10.1186/s13046-020-01757-x

Internet

http://link.springer.com/article/10.1186/s13046-020-01757-x

Similar Items